论文部分内容阅读
目的:观察补肾活血法治疗骨质疏松症的疗效。方法:将80例骨质疏松症患者随机分为治疗组与对照组各40例,对照组采用基础治疗,包括口服钙剂(碳酸钙D3咀嚼片)、阿法骨化醇片。治疗组在基础治疗上加口服补肾活血方,连续治疗3月。观察治疗前、治疗1月和3月后的目测类比评定法(VAS)疼痛评分,治疗前和治疗3月后的骨密度、疗效评价及生活质量评分。结果:2组疗效比较,差异有显著性意义(P<0.05),2组总有效率比较,差异有显著性意义(P<0.05),治疗组均优于对照组。2组治疗1月、3月后VAS评分与本组治疗前比较,差异均有非常显著性意义(P<0.01),而治疗组较对照组下降明显(P<0.01)。治疗前后2组骨密度比较,差异无显著性意义(P>0.05)。治疗3月后2组生活质量评分分别与本组治疗前比较,差异均有非常显著性意义(P<0.01),但治疗组较对照组改善更显著(P<0.01)。结论:补肾活血法可减轻骨质疏松症患者的疼痛,提高生活质量,值得推广。
Objective: To observe the effect of Bushen Huoxue Therapy on osteoporosis. Methods: Eighty patients with osteoporosis were randomly divided into treatment group (40 cases) and control group (40 cases). The control group received basic treatment, including oral calcium (calcium carbonate chewable tablets) and alfacalcidol tablets. Treatment group in the basic treatment plus oral Bushenhuoxue Fang, continuous treatment for 3 months. Visual acuity assessment (VAS) pain scores, bone mineral density before treatment and after 3 months of treatment, efficacy evaluation and quality of life scores were observed before treatment, after treatment for 1 month and 3 months. Results: There was significant difference between the two groups (P <0.05). There was significant difference between the two groups in the total effective rate (P <0.05). The treatment group was superior to the control group. The difference of VAS scores between the two groups in January and March after treatment was statistically significant (P <0.01), but decreased in the treatment group compared with the control group (P <0.01). There was no significant difference in bone mineral density between the two groups before and after treatment (P> 0.05). After 3 months of treatment, the quality of life scores of the two groups were significantly different from those before treatment (P <0.01), but the treatment group improved more significantly than the control group (P <0.01). Conclusion: Bushenhuoxue can alleviate the pain of patients with osteoporosis and improve the quality of life, it is worth promoting.